1-9 of 9
Sharad Khurana
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1b/2 Study of Escalating Doses of the NEDD8 Activating Enzyme Inhibitor Pevonedistat Administered in Combination with Standard Induction Therapy (Cytarabine and Idarubicin) in Newly Diagnosed High Risk Acute Myeloid Leukemia

Carissa M. Feliciano, Jennifer S. Carew, Hetty E. Carraway, Justin M. Watts, Sharad Khurana, Bhumika J. Patel, Keri Maher, Claudia Espitia, Kaijin Wu, Denice Tsao-Wie, Xuelian Chen, Mikkael A. Sekeres, Stan Louie, Homa Dadrastoussi, Eduardo Fernandez, Julian Olea, Brandon Sookdeo, Steffan T. Nawrocki, George Yaghmour, Kevin R. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 4279.
https://doi.org/10.1182/blood-2023-185481
Published: 2023
Journal Articles

Phase 1/2 Study of TP-3654, a Selective PIM1 Kinase Inhibitor: Preliminary Data Showed Clinical Activity and Cytokine Reductions in Relapsed/Refractory Myelofibrosis Patients

Lindsay A.M Rein, Firas El Chaer, Junichiro Yuda, Kazuya Shimoda, James McCloskey, Akiyoshi Takami, Tamanna Haque, Michiko Ichii, Shuichi Shirane, Masafumi Fukaya, Joseph M. Scandura, Terrence Bradley, Pankit Vachhani, Takayuki Tabayashi, Steven Green, Stanley Cheung, Prithviraj Bose, Sharad Khurana, Casey L. O'Connell, Idoroenyi Amanam, David M. Ross, Sujan Kabir, Masataka Seki, Mark Wade, Vishnu Peddagali, Zhonggai Li, Jatin Shah, Raajit K. Rampal
Journal: Blood
Blood (2023) 142 (Supplement 1): 626.
https://doi.org/10.1182/blood-2023-180164
Published: 2023
Journal Articles

Anti CD19 CAR-T Cell Therapy Can Clear Minimal Residual Disease in Bone Marrow of Patients with Relapsed or Refractory B Cell Non-Hodgkin's Lymphomas

Armaan Dhaliwal, Mahima Zandu, Sharad Khurana, Abhijeet Kumar, Jeffrey J. Pu, Emmanuel Katsanis, Muhammad Husnain
Journal: Blood
Blood (2022) 140 (Supplement 1): 12760–12761.
https://doi.org/10.1182/blood-2022-170620
Published: 2022
Journal Articles

Role of Anakinra in the Management of Steroid Refractory High Grade Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after Anti-CD 19 CAR-T Cell Therapy, a Single Center Experience

Ulyana Dashkevych, Nishant Munugala, Sharad Khurana, Abhijeet Kumar, Krisstina L. Gowin, Akshay Amaraneni, Ravi Krishnadasan, Jeffrey J. Pu, Emmanuel Katsanis, Muhammad Husnain
Journal: Blood
Blood (2022) 140 (Supplement 1): 12753–12754.
https://doi.org/10.1182/blood-2022-168240
Published: 2022
Journal Articles

Incidence and Outcomes of Cardiovascular Disease in Hemophilia Patients: An Analysis of National Inpatient Sample Database

Rohit Kumar, MD, Shruti Bhandari, MD, Sunny R K Singh, MD, Sindhu Malapati, MD, Sharad Khurana, MDMSc, Kamila I. Cisak, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2176.
https://doi.org/10.1182/blood-2019-127628
Published: 2019
Journal Articles

Identification of Targetable Tumor Associated Proteins in Adult T-Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Including a Novel CC-Chemokine 4 (CCR4)-Positive T-ALL/LBL with Unique Immunophenotype

Sharad Khurana, MDMSc, Michael G. Heckman, Jordan Cochuyt, Fiona E. Craig, MBBS, Zaid Abdel Rahman, MD, Patricia Greipp, DO, Lisa Z. Sproat, MD, Mark Litzow, MD, James M. Foran, MD, Liuyan Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 5210.
https://doi.org/10.1182/blood-2019-123286
Published: 2019
Journal Articles

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Lymphoblastic Leukemia (ALL): The Mayo Clinic Cohort

Zaid Abdel Rahman, MD, Michael G. Heckman, Kevin C. Miller, BS, Patricia Greipp, DO, Matthew R Spiegel, Sharad Khurana, MDMSc, Hassan B. Alkhateeb, MD, Mrinal M Patnaik, MDMBBS, Lisa Z. Sproat, MD, Liuyan Jiang, Vivek Roy, MD, Mark Litzow, MD, Mohamed A Kharfan-Dabaja, MDMBA, William J Hogan, MB, BCh, James M. Foran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2588.
https://doi.org/10.1182/blood-2019-122068
Published: 2019
Journal Articles

Decreased Physical Activity in Autologous Stem Cell Recipients Leads to Reduced QOL Scores during Hospitalization

Candice Baldeo, MBBS, Yenny Moreno Vanegas, MD, Sharad Khurana, MBBS, Madiha Iqbal, MBBS, Abdel-Ghani Azzouqa, MD, Taimur Sher, MD, Sikander Ailawadhi, Prakash Vishnu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5895.
https://doi.org/10.1182/blood-2018-99-112149
Published: 2018
Journal Articles

Lab Indicators of Iron Level in Bone Marrow Aspirate of Patients Diagnosed with Multiple Myeloma

Ankit Mangla, MBBS, MD, Sriman Swarup, MBBS, MD, Muhammad Umair Mushtaq, MBBS, MD, Hussein Hamad, MD, Sharad Khurana, MBBS, MD, Venkata Sravani Udayagiri, MBBS, MD, Marina Messinger, MD, Rose Catchatourian, MD
Journal: Blood
Blood (2015) 126 (23): 5397.
https://doi.org/10.1182/blood.V126.23.5397.5397
Published: 2015